Related Experiment Video
Updated: Dec 13, 2025

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
Cryopreserved Allograft Use in Vascular Surgery.
Jani Lee1, Mabel C Chan1, Crystal James1
1Mount Sinai Morningside and West Hospitals, New York, NY.
Cryopreserved arterial and venous allografts offer a superior alternative to prosthetic grafts in vascular surgery due to their resistance to infection. These allografts are increasingly the preferred choice for bypass procedures, including lower-extremity, aortic, and dialysis access applications.
Area of Science:
- Vascular Surgery
- Biomaterials Science
- Transplantation Immunology
Background:
- Bypass procedures are essential for treating arterial and venous diseases.
- Autogenous conduits are ideal but often unavailable.
- Prosthetic grafts are common but prone to infection.
Purpose of the Study:
- To discuss the clinical applications of cryopreserved arterial and venous allografts in vascular surgery.
- To highlight the advantages of allografts over prosthetic grafts, particularly regarding infection resistance.
- To focus on specific applications: lower-extremity bypass, aortic disease, and dialysis access.
Main Methods:
- Review of clinical applications and outcomes of cryopreserved allografts.
- Comparison of infection rates between allografts and prosthetic grafts.
- Analysis of suitability for various vascular reconstructions.
Main Results:
- Cryopreserved allografts demonstrate relative resistance to infection compared to prosthetic grafts.
- Allografts are effective conduits for lower-extremity peripheral bypass.
- Successful use of allografts in managing aortic disease and creating dialysis access.
Conclusions:
- Cryopreserved arterial and venous allografts are a valuable and infection-resistant option in vascular surgery.
- Their application in lower-extremity bypass, aortic disease, and dialysis access is clinically significant.
- Allografts represent a preferred conduit choice when autogenous options are not feasible and infection risk is a concern.
More Related Videos
05:25Author Spotlight: Exploring Cold Ischemia and Warm Reperfusion Injury in Fatty Liver Transplantation
Published on: December 1, 2023
09:36Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research
Published on: April 26, 2019